Hypersegmented megakaryocytes and megakaryocytes with multiple separate nuclei in dogs treated with PNU-100592, an

J E Lund1, P K Brown

  • 1Worldwide Toxicology, Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001, USA.

Insights

A toxicology study in beagle dogs revealed that the antibacterial agent PNU-100592 significantly increased abnormal megakaryocyte nuclear forms. This finding may offer insights into megakaryocytopoiesis regulation.

Area of Science:

  • Veterinary Pathology
  • Hematology
  • Toxicology

Background:

  • Megakaryocytes exhibit diverse nuclear morphologies in normal dogs, including multilobed and segmented nuclei.
  • Hypersegmentation and multiple separate nuclei are infrequent in canine megakaryocytes.

Purpose of the Study:

  • To evaluate the effects of PNU-100592, an oxazolidinone antibacterial, on megakaryocytopoiesis in young adult beagle dogs.
  • To investigate potential alterations in megakaryocyte nuclear morphology and platelet counts.

Main Methods:

  • A 1-month toxicology study was conducted using young adult beagle dogs.
  • Peripheral blood smears and bone marrow smears were analyzed.
  • Hematologic parameters, including platelet counts, were monitored.

Main Results:

  • PNU-100592 administration led to a notable increase in megakaryocytes with hypersegmented and multiple separate nuclei.
  • A slight decrease in mean platelet count was observed in most treated groups.
  • Siderocytes and ring sideroblasts were identified, indicating potential iron metabolism disturbances.

Conclusions:

  • PNU-100592 induces significant changes in canine megakaryocyte nuclear morphology.
  • The drug may impact megakaryocytopoiesis and platelet production.
  • PNU-100592 could serve as a tool for studying endomitosis regulation in canine megakaryocytopoiesis.

Related Concept Videos